SURG 📈 Surgepays - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US86882L2043
SURG: Mobile Services, ACH Banking, Fintech Transactions, Wireless Top-up, Lead Generation
SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee. Web URL: https://surgepays.com
Additional Sources for SURG Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SURG Stock Overview
| Market Cap in USD | 39m |
| Sector | Technology |
| Industry | Software - Application |
| GiC Sub-Industry | Wireless Telecommunication Services |
| IPO / Inception | 2005-09-22 |
SURG Stock Ratings
| Growth 5y | -87.7% |
| Fundamental | -22.4% |
| Dividend | - |
| Rel. Strength Industry | -291 |
| Analysts | 4/5 |
| Fair Price Momentum | 1.12 USD |
| Fair Price DCF | 12.84 USD |
SURG Dividends
No Dividends PaidSURG Growth Ratios
| Growth Correlation 3m | 11.8% |
| Growth Correlation 12m | -91.9% |
| Growth Correlation 5y | -63.7% |
| CAGR 5y | -35.14% |
| CAGR/Mean DD 5y | -0.50 |
| Sharpe Ratio 12m | -0.87 |
| Alpha | -87.61 |
| Beta | 0.62 |
| Volatility | 84.65% |
| Current Volume | 358.2k |
| Average Volume 20d | 360.8k |
What is the price of SURG stocks?
As of December 22, 2024, the stock is trading at USD 1.77 with a total of 358,160 shares traded.
Over the past week, the price has changed by -5.98%, over one month by +10.90%, over three months by +0.58% and over the past year by -68.14%.
As of December 22, 2024, the stock is trading at USD 1.77 with a total of 358,160 shares traded.
Over the past week, the price has changed by -5.98%, over one month by +10.90%, over three months by +0.58% and over the past year by -68.14%.
Is Surgepays a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Surgepays is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -22.38 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SURG as of December 2024 is 1.12. This means that SURG is currently overvalued and has a potential downside of -36.72%.
Neither. Based on ValueRay Fundamental Analyses, Surgepays is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -22.38 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SURG as of December 2024 is 1.12. This means that SURG is currently overvalued and has a potential downside of -36.72%.
Is SURG a buy, sell or hold?
Surgepays has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy SURG.
Surgepays has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy SURG.
- Strong Buy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for SURG stock price target?
According to ValueRays Forecast Model, SURG Surgepays will be worth about 1.2 in December 2025. The stock is currently trading at 1.77. This means that the stock has a potential downside of -30.51%.
According to ValueRays Forecast Model, SURG Surgepays will be worth about 1.2 in December 2025. The stock is currently trading at 1.77. This means that the stock has a potential downside of -30.51%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 6 | 239% |
| Analysts Target Price | 13 | 634.5% |
| ValueRay Target Price | 1.2 | -30.5% |